Janssen-Cilag International NV, a Johnson & Johnson company, has submitted an application to the European Medicines Agency ...

Chiesi UK and Ireland and Wirral Primary Care Collaborative (WPCC) have launched COMET, a programme designed to enhance early diagnosis and management of chronic obstructive pulmonary disease (COPD) ...

NICE reviewed various technologies and recommended DERM as the only AI tool suitable for NHS use. It is the first dermatology ...

Regeneron Pharmaceuticals has announced that the European Commission has conditionally approved Lynozyfic (linvoseltamab) for ...

Groundbreaking research has identified over 900 genetic links to osteoarthritis, including 500 previously undiscovered, in a ...

Lecanemab, currently licensed as a biweekly 10 mg/kg IV infusion, is developed by Eisai and Biogen to address the unmet needs of AD patients. AD, a chronic, progressive disease and the UK’s leading ...

Women in Pharma founders reflect on their progress and ambitions ...

At the heart of this evolution are Smart Hospitals – facilities that harness advanced technologies to enhance patient care, ...